
Sign up to save your podcasts
Or
On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.
4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.
6,237 Listeners
699 Listeners
465 Listeners
929 Listeners
38,560 Listeners
43,934 Listeners
90,537 Listeners
37,843 Listeners
30,674 Listeners
32,106 Listeners
935 Listeners
43,610 Listeners
387 Listeners
2,107 Listeners
1,617 Listeners